Panion & Bf Biotech Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 814.79 million compared to TWD 533.21 million a year ago. Net income was TWD 161.18 million compared to TWD 74.33 million a year ago. Basic earnings per share from continuing operations was TWD 1.88 compared to TWD 0.97 a year ago. Diluted earnings per share from continuing operations was TWD 1.88 compared to TWD 0.97 a year ago.
For the six months, sales was TWD 1,269.36 million compared to TWD 907.26 million a year ago. Net income was TWD 200.73 million compared to TWD 49.54 million a year ago. Basic earnings per share from continuing operations was TWD 2.34 compared to TWD 0.65 a year ago. Diluted earnings per share from continuing operations was TWD 2.34 compared to TWD 0.65 a year ago.